Understanding hairy cell leukemia genetics

Same author

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

BMC bioinformatics·2026

Same author

Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps Regimen.

Blood advances·2026

Same author

A novel JAK1 variant in chronic eosinophilic leukaemia with response to benralizumab.

British journal of haematology·2026

Same author

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

JCO precision oncology·2026

Same author

Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026

Same author

Augmenting Performance Status: A Preliminary Study of Objective Kinematic Assessment Using Motion Capture.

Oncology and therapy·2026

Same journal

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

Leukemia & lymphoma·2026

Same journal

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Leukemia & lymphoma·2026

Same journal

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

Leukemia & lymphoma·2026

Same journal

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

Leukemia & lymphoma·2026

Same journal

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Leukemia & lymphoma·2026

Same journal

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026

Related Experiment Videos

Understanding hairy cell leukemia genetics

Related Concept Videos

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps Regimen.

A novel JAK1 variant in chronic eosinophilic leukaemia with response to benralizumab.

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes.

Augmenting Performance Status: A Preliminary Study of Objective Kinematic Assessment Using Motion Capture.

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Related Experiment Videos

Understanding hairy cell leukemia genetics

Related Concept Videos

Related Articles

OpenIMC: an open-source platform for analyzing single-cell and spatial proteomics by imaging mass cytometry.

Low-Dose Vemurafenib Plus Rituximab in Front-Line and Relapsed or Refractory Hairy Cell Leukemia: The Scripps Regimen.

A novel JAK1 variant in chronic eosinophilic leukaemia with response to benralizumab.

Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

Dietary and Lifestyle Patterns Among Young Patients with Lung Cancer: Analysis of Mutation-Specific Phenotypes.

Augmenting Performance Status: A Preliminary Study of Objective Kinematic Assessment Using Motion Capture.

Leukemia mortality analysis in the pediatric population in São Paulo state, Brazil, 2000-2019.

CPX‑351 vs. FLAG‑ida in patients with high-risk AML/MDS and MDS-related gene mutations: a subgroup analysis of the UK NCRI AML19 trial.

Specialist palliative care access and end-of-life hospitalizations in acute leukemia: a nationwide register study.

D-VRD vs. D-KRD induction in transplant-eligible multiple myeloma: a real-world comparison.

T-box factor EOMES is part of an aberrant network in Hodgkin lymphoma.

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.